- Email Preferences
- Logout

+44 (0)20 8762 8008
Change Language
[Close]
- English
  
  Japanese
  
  English
Home
Overview
- Pandemic
- Bird Flu
Subscribers
Locations
Newsroom
- News
- Editorials
- FAQs

Quick Links

COVID-19

Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

Member Access

Travel Restrictions, Flight Operations and Screening

COVID-19 Digital Passports

Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID-19 Vaccine FAQs

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice

COVID-19 Disease and Prevention Article

Sign up for Emails and Alerts

Premium Services Member Access

COVID-19 Manager Advice

COVID-19 Case Definitions used by different authorities

Pandemic Local Impact Tool

COVID-19 Communication Material

COVID-19 Modelling

COVID-19 Useful Links

…
35
36
37
38
39
…

Vaccine update - around 60 percent of all adults had at least one dose
Mexico // 11 November, 2021
Around 70 percent of all adults have had at least one vaccine dose....
COVID-19
Recall of some Ellume COVID-19 Home Test kits due to potential for false positive results
United States // 11 November, 2021
Some kits have been showing a false positive result and are being recalled...
COVID-19
Moderna applies to EMA for vaccine approval in children 6-11 years
10 November, 2021
Moderna are seeking approval from the EMA...
COVID-19
Analysis of how COVID-19 went from an outbreak to a pandemic
09 November, 2021
An analysis of the early months of the pandemic has been released by the Independent Panel for Pandemic Preparedness and Response...
COVID-19
Rheumatism a risk for “long-COVID-19”
United States // 08 November, 2021
More than half of people with rheumatic diseases also experienced ‘long-COVID-19”…
COVID-19
Vaccine Update – mass vaccination initiative commences
Iraq // 08 November, 2021
Increased vaccination availability for those aged 12 and over...
COVID-19
Vaccine Update – Booster shots underway for certain groups
Jordan // 08 November, 2021
Booster shots are available to people from the following categories...
COVID-19
Vaccine Update – Pfizer/BioNTech for students aged 12 to 18 years, booster shots available
Barbados // 08 November, 2021
First doses of Pfizer/BioNTech have been prioritised for students aged 12 to 18 years...
COVID-19
Europe and Asia at epicentre of pandemic again
04 November, 2021
Europe and central Asia accounted for nearly two-thirds of all cases globally in the last week…
COVID-19
First oral antiviral for COVID-19, Molnupiravir (Lagevrio), approved by MHRA
United Kingdom // 04 November, 2021
Molnupiravir approved for use in UK...
COVID-19
Vaccine Update – Reservations for Booster shots begin
South Korea // 04 November, 2021
Advance vaccination reservations for adolescents aged 12 to 17 years and booster shots for a number of priority groups...
COVID-19
Digital vaccination certificate system in development
Taiwan (China) // 04 November, 2021
Taiwan has completed designing a digital vaccine certificate system...
COVID-19
Digital vaccination certificate will be available end of November
New Zealand // 04 November, 2021
People aged 16 years and above will be able to download a digital vaccination certificate...
COVID-19
PAHO warns against complacency as cases drop
03 November, 2021
Cases have declined for eight weeks…
COVID-19
World Health Organisation issues Emergency Use Listing for COVAXIN®
03 November, 2021
WHO grant Emergency Use Listing to COVAXIN vaccine...
COVID-19
Vaccine update - Booster doses now being offered
Netherlands // 03 November, 2021
Booster doses offered to increased risk groups...
COVID-19
Studies of Pfizer/BioNTech booster shots show enhanced protection
Israel // 03 November, 2021
Booster shots were found to offer substantial protection...
COVID-19
COVID-19 Update – Majority of cases reported near capital
Botswana // 02 November, 2021
Cases in Botswana have been on a declining trend since peaking in early August...
COVID-19
Indonesia approves Novavax for emergency use
Indonesia // 01 November, 2021
Serum Institute of India to manufacture…
COVID-19
FDA delays decision on Moderna use in adolescents
United States // 01 November, 2021
Review may not be complete until early 2022…
COVID-19

…
35
36
37
38
39
…

Additional data provided by

© 2024 International SOS